PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Promising results for Swedish cancer drug candidate

2013-12-06
(Press-News.org) Contact information: The Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Promising results for Swedish cancer drug candidate A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School and Karolinska Institutet in Sweden presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.

The journal Blood has published a new study on a drug candidate for multiple myeloma, a form of cancer that affects about one per cent of all tumour patients, with some 600 people a year developing the disease in Sweden. Multiple myeloma is a life-threatening disease and there is a dire medical need for new therapies, especially for the patients whose tumour cells have become resistant to the conventional drugs.

"The discovery that our substance works on multiple myeloma cells resistant to conventional therapy is very promising for the future," says Professor Stig Linder at Karolinska Institutet's Department of Oncology-Pathology. "We're now very hopeful that we and our colleagues at Harvard Medical School will be able to develop an effective treatment."

The study demonstrates that the drug candidate, called VLX1570, inhibits tumour growth and prolongs survival in preclinical multiple myeloma models. The exact mechanism of action of the substance was identified earlier at Karolinska Institutet (Nature Medicine, 2011); put simply, the tumour cells can be said to be more sensitive than normal cells to disruption to the machinery that breaks down defective proteins. When this machinery is blocked, it triggers apoptosis (programmed cell death) in the tumour cells.

"We show that the drug candidate kills multiple myeloma cells from cancer patients," says Professor Linder. "The substance is also effective against myeloma cells that have developed a resistance to the clinically used drug bortezomib."

Dr Dharminder Chauhan at Harvard Medical School says that the mechanism of action is very interesting as regards the development of new cancer drugs and adds, "We're delighted to be able to study the therapeutic potential of this new drug candidate in clinical studies. We hope that the joint research we're doing will lead to improved cancer treatments."

The study also found that the new substance could be combined synergistically with other cancer therapies. Karolinska Institutet and Harvard Medical School are due to launch a large-scale clinical study next year in association with drug discovery company Vivolux AB (Uppsala, Sweden).

"If the study proves successful it will represent a great step forward, mainly for all cancer patients but also for the Swedish drug industry," says Professor Linder.

### The research was funded by the NIH, the American Cancer Society, the Swedish Cancer Society, the Swedish Research Council, Alex and Eva Wallström Foundation, Åke Olsson Foundation, the Cancer Research Foundations of Radiumhemmet, the Swedish Foundation for Strategic Research, and Vivolux AB.

Publication: 'A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in myeloma cells and overcomes Bortezomib resistence', Tian Z, D'Arcy P, Wang X, Ray A, Tai Y-T, Hu Y, Carrasco R, Linder S, Chauhan D, Anderson K, Blood, online 6 December 2013.

Contact the Press Office and download images: ki.se/pressroom

Journal website: bloodjournal.hematologylibrary.org

Karolinska Institutet - a medical university: ki.se/english


ELSE PRESS RELEASES FROM THIS DATE:

Surprising discovery: The skin communicates with the liver

2013-12-06
Surprising discovery: The skin communicates with the liver Researchers from the University of Southern Denmark have discovered that the skin is capable of communicating with the liver. The discovery has surprised the scientists, and they say that it may help our understanding ...

Human stem cells predict efficacy of Alzheimer drugs

2013-12-06
Human stem cells predict efficacy of Alzheimer drugs Researchers from the University of Bonn use reprogrammed patient neurons for drug testing Why do certain Alzheimer medications work in animal models but not in clinical trials in humans? A research team ...

New study finds corn oil superior to extra virgin olive oil in lowering cholesterol

2013-12-06
New study finds corn oil superior to extra virgin olive oil in lowering cholesterol Plant sterols naturally found in corn oil linked to heart health benefits WASHINGTON, December 6, 2013 – Corn oil significantly reduces cholesterol with more favorable changes ...

Enzalutamide in prostate cancer: Hints of added benefit

2013-12-06
Enzalutamide in prostate cancer: Hints of added benefit Longer overall survival in patients without visceral metastases / bone complications and pain progression delayed Enzalutamide (trade name: Xtandi) has been approved since ...

Study finds parental stress linked to obesity in children

2013-12-06
Study finds parental stress linked to obesity in children Effects on Hispanic children more pronounced TORONTO, Dec. 6, 2013—Parental stress is linked to weight gain in children, according to a new study from St. Michael's Hospital. The study found that children ...

What is the link between erectile dysfunction and heart disease?

2013-12-06
What is the link between erectile dysfunction and heart disease? New Rochelle, NY, December 6, 2013—Erectile dysfunction (ED) is caused by the inability of the artery that supplies blood to the penis to expand and contract properly. The ...

Coal yields plenty of graphene quantum dots

2013-12-06
Coal yields plenty of graphene quantum dots Rice U. scientists find simple method for producing dots in bulk from coal, coke HOUSTON – (Dec. 6, 2013) – The prospect of turning coal into fluorescent particles may sound too good to be true, but the possibility exists, thanks ...

Graphene: Growing giants

2013-12-06
Graphene: Growing giants Huge grains of copper promote better graphene growth WASHINGTON D.C. Dec. 6, 2013 -- To technology insiders, graphene is a certified big deal. The one-atom thick carbon-based material elicits rhapsodic descriptions as the strongest, ...

1 percent of the population is responsible for 63 percent of violent crime convictions

2013-12-06
1 percent of the population is responsible for 63 percent of violent crime convictions The majority of all violent crime in Sweden is committed by a small number of people. They are almost all male (92%) who early in life develops violent criminality, substance abuse ...

Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students

2013-12-06
Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students Today, smartphones are central to college students' lives, keeping them constantly connected with friends, family and the Internet. Students' cell phones are rarely out of reach ...

LAST 30 PRESS RELEASES:

Heatwaves linked to rise in sleep apnoea cases in Europe

Down‑top strategy engineered large‑scale fluorographene/PBO nanofibers composite papers with excellent wave‑transparent performance and thermal conductivity

The Lancet: Climate change inaction being paid for in millions of lives every year

New insights reveal how coral gets a grip

Home treatment with IV antibiotics could relieve NHS pressure

AI ECG better detects severe heart attacks in emergency setting

Straw-based biochar and smart irrigation help maize thrive with less water and fertilizer

‘Broken’ genes a common factor in marsupial fur colour

Turning waste into clean water: Magnetic carbon materials remove toxic pollutants from wastewater

World Health Organization’s priorities shaped by its reliance on grants from donor organisations such as the Gates Foundation

One in ten people without coeliac disease or wheat allergy report sensitivity to gluten or wheat

How can (A)I help you?

Study finds new system can cut patient waiting times for discharge

Allison Institute’s third annual scientific symposium highlighted by panel discussion with five Nobel laureates

SETI Institute accelerates the search for life beyond earth with NVIDIA IGX Thor

Wetlands efficiently remove nitrogen pollution from surface water, leading to cost savings for municipalities

Dr. Loren Miller presents oral late breaker at IDWeek 2025 of a first-of-its-kind clinical trial that shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia

Dirty water boosts prospects for clean hydrogen

New multisociety guidance strengthens infection prevention and control in nursing homes

More scientific analysis needed on impacts of industrial decarbonization

New research uncovers how bad bacteria know where to cluster and cause infection

As ochre sea star ‘baby boomers’ grow up, species showing signs of recovery

Six-million-year-old ice discovered in Antarctica offers unprecedented window into a warmer Earth

When it comes to mating, female mosquitoes call the shots

CZI and NVIDIA accelerate virtual cell model development for scientific discovery

JMIR Publications and MCBIOS partner to boost open access bioinformatics research

Canadian scientists describe an extinct rhino species from Canada's High Arctic

Houseplant inspires textured surfaces to mitigate copper IUD corrosion

LIGO, Virgo and KAGRA observed “second generation” black holes

Dicer: Life's ancient repair tool

[Press-News.org] Promising results for Swedish cancer drug candidate